|
1. Lewiecki EM. Management of
Osteoporosis. Clin Mol Allergy 2004;14:9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15253771. |
2. Ettinger B, Grady D. The waning
effect of postmenopausal estrogen therapy on osteoporosis. N
Engl J Med. 1993;329:1192-1193. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8377785. |
3. Stampfer MJ, Colditz GA, Willett
WC, et al. Postmenopausal estrogen therapy and cardiovascular
disease. Ten-year follow-up from the Nurses’ Health
Study. N Engl J Med. 1991;325:756-762. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1870648. |
4. Henderson NK, White CP, Eisman
JA. The roles of exercise and fall risk reduction
in the prevention of osteoporosis. Endocrinol
Metab Clin N Amer. 1998;27:369-387http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9669143. |
5. Physician’s Guide to
Prevention and Treatment of Osteoporosis. 2nd ed.
Washington, DC: National Osteoporosis Foundation;
2003. http://www.nof.org/. |
6. National Osteoporosis Foundation.
Osteoporosis: review of the evidence for prevention,
diagnosis and treatment and cost-effectiveness analysis.
Osteoporosis Int. 1998;8(suppl 4):1-88. |
7. Dawson-Hughes B, Harris SS,
Krall EA, Dallal GE. Effect of calcium and vitamin
D supplementation on bone density in men and women
65 years of age or older. N Engl J Med. 1997;337:670-676. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9278463. |
8. Chapuy MC, Arlot ME, Duboeuf
F, et al. Vitamin D3 and calcium to prevent hip fractures
in elderly women. N Engl J Med. 1992;327:1637-1642. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1331788.
|
9. Lilliu H, Pamphile R, Chapuy
MC, Schulten J, Arlot M, Meunier PJ. Calcium-vitamin
D3 supplementation is cost-effective in hip fractures
prevention. Maturitas. 2003;44:299-305. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12697371. |
10. Hodgson SF, Watts NB, Bilezikian
JP, et al. American Association of Clinical Endocrinologists
medical guidelines for clinical practice for the prevention
and treatment of postmenopausal osteoporosis: 2001
edition, with selected updates for 2003. Endocr
Pract. 2003;9:544-564. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14715483. |
11. ACOG practice bulletin. Clinical
management guidelines for obstetrician-gynecologists.
Obstet Gynecol. 2004;103:203-216. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14704265. |
12. Sotelo MM, Johnson SR. The
effects of hormone replacement therapy on coronary
heart disease. Endocrinol Metab Clin N Amer.
1997;26:313-328. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9193886. |
13. Papadimitropoulos E, Wells
G, Shea B, et al. Meta-analyses of therapies for postmenopausal
osteoporosis. VIII: Meta-analysis of the efficacy
of vitamin D treatment in preventing osteoporosis
in postmenopausal women. Endocr Rev. 2002;23:560-569. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12202471. |
14. Heaney RP, Weaver CM. Calcium
and vitamin D. Endocrinol Metab Clin North Am.
2003;32:181-194, vii-viii. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12699298. |
15. Pettifor JM. Primer on the
metabolic bone diseases and disorders of mineral metabolism.
5th ed. Washington, DC: American Society for Bone
and Mineral Research; 2003. |
16. Daniell HW. Osteoporosis
of the slender smoker. Vertebral compression fractures
and loss of metacarpal cortex in relation to postmenopausal
cigarette smoking and lack of obesity. Arch Intern
Med. 1976;136:298-304. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=946588. |
17. Hopper JL, Seeman E. The
bone density of female twins discordant for tobacco
use. N Engl J Med. 1994;330:387-39225. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8284003. |
18. Burger H, de Laet CE, van
Daele PL, et al. Risk factors for increased bone loss
in an elderly population: the Rotterdam Study. Am
J Epidemiol. 1998;147:871-879. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9583718. |
19. Rubenstein LZ, Robbins AS,
Josephson KR, Schulman BL, Osterweil D. The value
of assessing falls in an elderly population. A randomized
clinical trial. Ann Intern Med. 1990;113:308-316. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2115755. |
20. Grisso JA, Kelsey JL, Strom
BL, et al. Risk factors for falls as a cause of hip
fracture in women. The Northeast Hip Fracture Study
Group. N Engl J Med. 1991;324:1326-1331. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2017229. |
21. Bischoff-Ferrari HA, Dawson-Hughes
B, Willett WC, et al. Effect of Vitamin D on falls:
a meta-analysis. JAMA. 2004;291:1999-2006. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15113819. |
|
|
